NervGen Pharma Corp.
NGEN.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.12% | -47.54% | -40.78% | -55.01% | 35.93% |
| Total Receivables | -81.72% | 5,545.83% | 1,250.00% | 2,791.00% | 87.97% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 42.41% | 31.75% | -44.54% | 43.73% | 149.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -72.39% | -12.67% | -0.21% | -50.52% | 73.41% |
| Total Current Assets | 25.84% | -44.07% | -39.48% | -53.39% | 39.43% |
|
|
|||||
| Total Current Assets | 25.84% | -44.07% | -39.48% | -53.39% | 39.43% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.64% | -14.30% | -11.00% | -16.16% | -18.06% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 24.99% | -43.52% | -39.10% | -53.05% | 35.13% |
|
|
|||||
| Total Accounts Payable | -13.79% | -91.76% | -92.98% | -95.48% | -99.08% |
| Total Accrued Expenses | -1.00% | 77.40% | 64.17% | 59.09% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.98% | -66.29% | -38.70% | -17.18% | -2.59% |
| Total Finance Division Other Current Liabilities | 33.28% | 5.14% | 9.44% | -0.46% | -7.15% |
| Total Other Current Liabilities | 33.28% | 5.14% | 9.44% | -0.46% | -7.15% |
| Total Current Liabilities | 22.52% | 17.28% | 16.71% | 5.72% | 2.46% |
|
|
|||||
| Total Current Liabilities | 22.52% | 17.28% | 16.71% | 5.72% | 2.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -92.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.46% | 16.99% | 16.27% | 5.05% | 1.81% |
|
|
|||||
| Common Stock & APIC | 33.12% | 9.02% | 10.85% | -2.68% | 26.46% |
| Retained Earnings | -50.04% | -24.26% | -30.90% | -24.18% | -20.55% |
| Treasury Stock & Other | 106.32% | 15.32% | 25.01% | 20.92% | 28.13% |
| Total Common Equity | 41.60% | -131.09% | -107.38% | -93.05% | 217.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.60% | -131.09% | -107.38% | -93.05% | 217.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.60% | -131.09% | -107.38% | -93.05% | 217.72% |
|
|
|||||